Creative Biolabs

Creative Biolabs introduced the discovery of biomolecular approaches targeting Plasmodium, aiming to assist academia and the pharmaceutical industry in relieving the malaria health crisis.

Creative Biolabs is proud to announce its new-year resolution to dive deeper into sourcing professional animal model solutions for neurological disorder studies.

With the spotlight on mRNA vaccines post the prestigious Nobel Prize in Physiology or Medicine 2023, Creative Biolabs stands poised to revolutionize this groundbreaking technology.

Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.

Creative Biolabs updated its NAA solution, which was designed to provide invaluable insights into autoimmune diseases and autoantibody profiling and promises to propel the field of

Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.

Creative Biolabs updated strategies in order to help achieve success in immunotherapy discovery.

A newly released market research reports on the prosperous future of exosome research.

Creative Biolabs expressed hopes that further progress could be made in the field of exosome research.

A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry.